Dysplastic naevus: 20 Years of discussion;Dysplastischer navus: 20 Jahre diskussion

H+G Zeitschrift fur Hautkrankheiten

Volumn 73, Issue 7-8, 1998, Pages 456-464

  Kaskel, P ^a,c   Sander, C A ^a   Krahn G ^b   Kind, P ^b  

^a Abteilung Dermatologie

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Dysplastic nevus; Epidemiology; Genetics; Review; Therapy, familiar melanoma

Indexed keywords

CLINICAL EXAMINATION; DYSPLASTIC NEVUS; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; MELANOMA; NOMENCLATURE; REVIEW;

EID: 0031881068     PISSN: 03010481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Ackerman A. und Mihara l (1985) Dysplasia, Dysplastic Melanocytes, Dysplastic Nevi, the Dysplastic Nevus Syndrome, and the Relation Between Dysplastio Nevi and Malignant Melanomas. Human Pathol 16:87-91
2. Ackerman A, Magana-Garcia M, DiLeonardo M (1990) Naming Acquired Melanocytic Nevi. Unna's, Miescher's, Spitz's, and Clark's? Am J Dermatopathol 12,193-209
3. Bataille V, Newton-Bishop J, Sasieni P, Swerdlow A, Pinney E, Griffiths K, Cuzick J (1996) Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. BrJ Cancer 73:1605-1611
4. Becker S (1954) Critical Evaluation of thaSoCalled "Junction Nevus". J Invest Dermatol 22: 217-223
5. Bondi E, Clark W, Elder D, DuPont G, Greene M (1981) Topical Chemotherapy of Dysplastic Melanocytic Nevi With 5% Fluorouracil. Arch Dermatol 117:89-92
6. Cannon-Albright L, Kamb A, Skolnick M (1996) A Review of Inherited Predisposition to Melanoma. Semin Oncol 23: 667-672
7. Clark W, Reimer R, Greene M, Ainsworth A, Mastrangelo M (1978) Origin of Familial Malignant Melanomas From Heritable Melanocytic Lesions. "The B-K Mole Syndrome". Arch Dermatol 114: 732-738
8. Clark W, Elder D, Guerry D, Epstein M, Greene M, Horn M van (1984) A Study of Tumor Progression: The Precursor Lesions of Superficial Spreading and Nodular Melanoma. Hum Pathol 14:1147-1165
9. Clark W und Ackerman A (1989) An Exchange of Views Regarding the Dysplastic Nevus Controversy. Semin Dermatol 8: 229-250
10. Elder D, Goldman L, Goldman S, Greene M, Clark W (1980) Dysplastic Nevus Syndrome: A Phenotypic Association of Sporadic Cutaneous Melanoma. Cancer 46:1787-1794
11. Elder D (1985) The Dysplastic Nevus. Pathol 17: 291-297
12. Gartmann H (1962) Besteht ein histologischer Unterschied -zwischen der problastomatösen Melanose und dem .activated junctional nevus" (Allen)? Ein Beitrag zur Entstehungsweise des Melanoms. Hautarzt 13:507-511
13. Gartmann H (1984) Was sind dysplastische Nävi? Hautarzt 35:3-6
14. Goldstein A, Goldin L, Dracopoli N, Clark W, Tucker M (1996) Two-Locus Linkage Analysis of Cutaneous Malignant Melanoma/ Dysplastic Nevi. Am J Hum Genet 58: 10SO1056
15. Halpem A, DuPont G, Elder D, Clark W, Synnestvedt M, Norman S, Ayerle R (1991) Dysplastic Nevi as Risk Markers of Sporadic (Nonfamilial) Melanoma. A Case-Control Study. Arch Dermatol 127: 995-999
16. Healy E, Sikkink S, Rees J (1996) Infrequent Mutation of p16ink4 in Sporadic Melanoma. J Invest Dermatol 107:318-321
17. Hesse G, Schmoeckel C, Wichmann-Hesse A. (1994) Mikrofilmdokumentation in der Verlaufskontrolle von melanozytären Nävi. Hautarzt 45: 532-535
18. Holländer A (1927) Referat über den Artikel Die Entstehung der bösartigen Melanome der Haut, von G. Miescher" Dermatol Wschr 37:1308
19. Kamb A (1996) Human Melanoma Genetics. J Invest Dermatol 1:177-182
20. Kamino (1996) Blue nevi. Vortrag auf der Jahrestagung der Arbeitsgemeinschaft Dermatologische Histologie München.
21. Kang S, Bamhill R, Mihm M, Fitzpatrick T, Sober A (1994) Melanoma Risk in Individuals With Clinically Atypical Nevi. Arch Dermatol 130:999-1001
22. Knudson A (1971) Mutation and Cancer: Statistical Study of Retinoblastoma. Proc Natl Acad Sei USA 68: 820-823
23. Knudson A (1993) Antioncogenes and human cancer. Proc Natl Acad Sei USA 90: 10914 10921
24. Kopf A, Friedman R, Rigel D (1989) Atypical Mole Syndrome. J Am Acad Dermatol y: 117-118
25. Kraehn G, Schartl M, Peter R (1994) Human Malignant Melanoma. A Genetic Disease? Cancer 75:1228-1237'
26. Kraehn G, Peter R, Kaudewitz P (1997) Rationelle Diagnostik des Melanoms. Münch Med Wschr 139:58-61
27. Lynch H, Frichot B, Lynch J (1978) Familial atypical mole melanoma syndrome. J Med Genet 15:352-356
28. Lynch H, Fusaro R, Johnsen L, Lynch J (1991) Hereditary Malignant Melanoma and the FAMMM Syndrome, in: Lynch H und Fusaro R (Hrsg) Hereditary Malignant Melanoma. CRC Press, Boca Raton (Florida, USA) 1-24
29. Marghoob A, Kopf A, Rigel D, Bart R, Friedman R, Yadav S, Abadir M, Sanfilippo L, Silverman M, Vossaert K (1994) Risk of Cutaneous Malignant Melanoma in Patients With Classical" Atypical-Mole Syndrome. A Case-Control Study. Arch Dermatol 130:993-998
30. Marghoob A, Slade J, Kopf A, Salopek T, Rigel D, Bart R (1996) Risk of developing multiple cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study. Br J Dermatol 135: 704-711
31. Massi D, Nielsen T, Ackerman B (1997) Melanocytic Dysplasia, Dysplastic Nevus, and Dysplastic Nevus Syndrome: Myth! Part IV. Dermatopathol 3: 38-59
32. McCalmont T (1994) The Clinical Context: a Tool for Fine-Tuning Objective Histologie Diagnosis of Cutaneous Pigmented Lesions, in: LeBoit P (Hrsg) Pathology. State of the Art Reviews. Malignant Melanoma and Melanocytic Neoplasms. Hanley und Belfus, Philadelphia (USA) 2:143-180
33. Miller T und Pack G (1962) The Familial Aspect of Malignant Melanoma. Arch Dermatol 86: 83-87
34. Nachbar F, Stolz W, Merkle T, Cognetta A, Vogt T, Landthaler M, Bilek P, Braun-Falco O, Plewig G (1994) The ABCD rule of dermatoscopy. J Am Acad Dermatol 30: 551-559
35. Nakano J, Mohan-Raj B, Asagami C, Uoyd K (1996) Human Melanoma Cell ünes Deficient in GD3 Ganglioside Expression Exhibit Altered Growth and Tumorigenic Characteristics. J Invest Dermatol 107:543-548'
36. NIH Consensus Conference (1984) Precursors to Malignant Melanoma. JAMA 251:1864-1866
37. NIH Consensus Conference (1992) Diagnosis and Treatment of Early Melanoma. NIH Consensus Development Panel on Early Melanoma. JAMA 268:1314-1319
38. Peter RU, Worret W, Nickolay-Kiesthardt J (1992) Prevalence of Dysplastic Nevi in Healthy Young Men. Int J Dermatol 31: 327-330
39. Piepkorn M (1994) A Perspective on the Dysplastic Nevus Controversy, in: LeBoit P (Hrsg) Pathology. State of the Art Reviews. Malignant Melanoma and Melanocytic Neoplasms. Hanley und Belfus, Philadelphia (USA) 2:259-280
40. Rigel D, Rivers J, Kopf A, Friedman R, Vinokur A, Heilman E, Levenstein M (1989) Dysplastic Nevi. Markers for Increased Risk for Melanoma. Cancer 63: 386-389
41. Robson J und Diffey B (1990) Textiles and sun protection. Photodermatol Photoimmunol Photomed 7:32-34
42. Sander C, Tschochohei H, Hagedorn M (1989) Zur Epidemiologie des dysplastischen Nävus. Hautarzt 40: 758-760
43. Schmoeckel C (1988) Dysplastischer Nävuskontra. Hautarzt Suppl VIII27-28
44. Schneider J, Moore D, Sagebiel R (1994) Risk Factors for Melanoma Incidence in Prospective Follow-Up. The Importance of Atypical (Dysplastic) Nevi. Arch Dermatol 130:1002-1007
45. Sebastian G, Breuninger H, Müller R (1997) Qualitätssicherung in der operativen und onkologischen Dermatologie: Stellungnahme der VOD zur Therapie erworbener Nävuszellnävi. Hautarzt 48: 705-706
46. Shapiro P (1992) Making Sense of the Dysplastic Nevus Controversy. A Unifying Perspective. Am J Dermatopathol 14:350-356
47. Skender- Kalnenas T, English D, Heenan P (1995) Benign melanocytic lesions: Risk marker or precursors of cutaneous melanoma. J Am Acad Dermatol 33:1000-1007
48. Slade J, Salopek T, Marghoob A, Kopf A, Rigel D (1995) Risk of Developing Cutaneous Malignant Melanoma in Atypical Nevus Syndrome: New York University Experience and Lierature Review. Rec Results Cancer Research 139: 87-104
49. Tronnier M, Neumann M, Alexander M, Brinckmann J (1997) Attachment and chemotaxis of melanocytes in vitro after UV-irradiation. Pigment Cell Res 10:338
50. Voss C (1952) Zum Naevusproblem (Naevus pigmentosus, Naevus mollis und die Herkunft der sogenannten Naevuszellen. Theorien und eigene Ergebnisse). Arch Dermatol Syph 194: 30-83
51. Weinberg R (1989) Oncogenes, Antioncogenes, and the Molecular Bases of MultiStep Carcinogenesis. Cancer Res 49:3713-3721
52. Weinstock M (1994) Dysplastic nevi revisited. J Am Acad Dermatol 30: 807-810